US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
ReShape Lifesciences Inc (RSLS)
ReShape Lifesciences Inc (RSLS) ニュース

RSLS

ReShape Lifesciences (RSLS)

ReShape Lifesciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RSLS

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/21	06 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/05/16	05 : 50	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/05/16	05 : 05	GlobeNewswire Inc.	ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/05/14	21 : 31	GlobeNewswire Inc.	ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/04/02	05 : 05	GlobeNewswire Inc.	ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/03/28	21 : 31	GlobeNewswire Inc.	ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/03/04	22 : 31	GlobeNewswire Inc.	ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/02/27	06 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/02/22	22 : 31	GlobeNewswire Inc.	ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/01/24	22 : 31	GlobeNewswire Inc.	ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/01/19	06 : 38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/01/17	08 : 11	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/01/06	06 : 14	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/12/20	22 : 31	GlobeNewswire Inc.	ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/12/13	06 : 05	GlobeNewswire Inc.	ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/11/30	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/11/21	22 : 06	GlobeNewswire Inc.	ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/11/09	06 : 05	GlobeNewswire Inc.	ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/11/06	22 : 31	GlobeNewswire Inc.	ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/10/14	05 : 42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/10/06	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/10/03	22 : 23	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/30	01 : 30	GlobeNewswire Inc.	ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/28	06 : 30	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/23	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/22	21 : 31	GlobeNewswire Inc.	ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/21	21 : 31	GlobeNewswire Inc.	ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/19	21 : 31	GlobeNewswire Inc.	ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/14	21 : 31	GlobeNewswire Inc.	ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ Device	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/08/26	05 : 41	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:RSLS	ReShape Lifesciences Inc

Showing the most relevant articles for your search:NASDAQ:RSLS

1 2 3 4 5 6 次へ >>

Bank of Montreal Autocal...

Royal Bank of Canada Cap...

Bnp Paribas null

Energix Renewable Energies (PK)

NLBNPIT1XGX2 20240620 36...

Vontobel Financial Produ...

First North All Share SEK

United American Petroleum (PK)

NLBNPIT1UC46 20991231 28...

LAI [CryptoGPT Token]

Bretagne Region 0.145% d...

Alto Neuroscience

NLBNPIT1YYD5 20991231 21...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約